Navigation Links
New Study Finds Growth Factor Boosts Productivity in Mammalian Cell Culture
Date:10/10/2008

Leading researchers in academia and industry reveal powerful effects of recombinant lactoferrin (tradename: Lacromin) in mammalian cell culture

leading to a significant boost in productivity.

FORT COLLINS, Colo., Oct. 10 /PRNewswire/ -- A recently published study in the scientific journal In Vitro Cellular & Developmental Biology revealed that recombinant lactoferrin (tradename: Lacromin, see http://www.Lacromin.com) is a strong growth factor for promoting cell growth and cell productivity across a variety of cell lines, including intestinal cells, hybridoma cells, osteoblast cells and embryonic kidney (293) cells.

A global collaborative research effort led to the findings. The study included research conducted by two prestigious international research institutions: University of Auckland in New Zealand and Barts & The London Queen Mary's School of Medicine & Dentistry in London. Also, cell culture industry researchers at the following companies contributed to these findings:

-- HyClone Inc in Logan, Utah;

-- KC Bio in Kansas City, Missouri; and

-- InVitria in Fort Collins, Colorado.

Dr. Ning Huang, Vice President of Research and Development for InVitria, coordinated the study entitled, "Bioactive recombinant human lactoferrin, derived from rice, stimulates mammalian cell growth (1)."

"In working with research collaborators in the industry and leading academic centers around the world, recombinant lactoferrin has been shown to promote cell growth and productivity in a variety of cell lines and also improves antibody product yields in mammalian cell culture," said Dr. Huang. "Since recombinant lactoferrin is well defined, it is an important component for adapting cells and transitioning cells from serum to animal free and completely defined cell culture media."

"We have discovered that recombinant lactoferrin is an important growth factor in bone cell culture media," said Professor Jillian Cornish, Department of Medicine, Faculty of Health and Medical Sciences at University of Auckland. "Not only did we see improved growth of osteoblasts, but we also found that growth increased with greater amounts of recombinant lactoferrin."

About InVitria (http://www.InVitria.com)

InVitria has developed cell culture media components that enhance productivity, safety and time to market for companies in the biopharmaceutical, mammalian cell culture, regenerative medicine, cell therapy, stem cell and diagnostics industry. InVitria's recombinant human lactoferrin called Lacromin (http://www.Lacromin.com) was utilized in this study.

For more detailed product information requests or to order re-prints of the above-mentioned article contact InVitria by e-mail or phone.

E-mail: info@InVitria.com Phone: 1-800-916-8311

(1) Huang, N. et al. Bioactive recombinant human lactoferrin, derived from

rice, stimulates mammalian cell growth. In Vitro Cellular &

Developmental Biology. September 19, 2008 (E-publication Date).


'/>"/>
SOURCE InVitria
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Facet Solutions Completes Facet Joint and Disc Replacement Study
2. Memory Pharmaceuticals Completes Phase 1 Multiple Ascending Dose Study of R4996/MEM 63908
3. Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants
4. Emisphere Announces Recruitment Phase III Study for Oral Osteoarthritis Treatment
5. Eklin Medical Surpasses 1,000th RapidStudy(R) Digital Radiography System Installation Featuring Canon DR Technology
6. Oil palm plantations are no substitute for tropical rainforests, a new study shows
7. Global Study Shows That Majority of Women with Osteoporosis Do Not Consider Themselves at Higher Risk for Fractures
8. New Study by BioTrends Highlights Anemia Practice Patterns According to Anemia Managers in Both Dialysis Units and CKD Clinics/Offices
9. Sanofi Aventis : New Study Results Support the "Basal Plus" Strategy With LANTUS(R) and APIDRA(R) to Improve Blood Sugar Control in Patients With Type 2 Diabetes
10. Germicidal UVC Lights Improve Clinical Pregnancy Rates for IVF Lab, New Study Finds
11. ESBATech Announces Successful Completion of Phase I Clinical Study for Lead Antibody Fragment in Ophthalmic Indications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... ... October 10, 2017 , ... ... process optimization firm for the life sciences and healthcare industries, announces a presentation ... San Francisco. , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will ...
(Date:10/9/2017)... ... October 09, 2017 , ... At its national board meeting ... a professor in Harvard University’s Departments of Physics and Astronomy, has been selected for ... of the winning team for the 2015 Breakthrough Prize in Fundamental physics for the ...
(Date:10/7/2017)... WA (PRWEB) , ... October ... ... industry leader in Hi-C-based genomic technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution ... ProxiMeta Hi-C kit and accompanying cloud-based bioinformatics software to perform Hi-C metagenome ...
(Date:10/5/2017)... (PRWEB) , ... October 05, 2017 , ... LabRoots ... and scientists from around the world, is giving back to cancer research with a ... October. , Now through October 31, shoppers can use promo code PinkRibbon to ...
Breaking Biology Technology:
(Date:4/11/2017)... Fla. , April 11, 2017 ... and secure authentication solutions, today announced that it ... Intelligence Advanced Research Projects Activity (IARPA) to develop ... Thor program. "Innovation has been a ... IARPA,s Thor program will allow us to innovate ...
(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
(Date:4/5/2017)... 2017 Today HYPR Corp. , leading ... component of the HYPR platform is officially FIDO® ... security architecture that empowers biometric authentication across Fortune 500 ... secured over 15 million users across the financial services ... home product suites and physical access represent a growing ...
Breaking Biology News(10 mins):